Business
How Will Cellectis ADR (NASDAQ: CLLS) Perform In The Next Few Months?
Cellectis ADR (NASDAQ:CLLS) has a beta value of 3.25 and has seen 77558.0 shares traded in the last trading session. The company, currently valued at
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
